once daily glp 1 A New Option in Weight Management A new once-daily oral GLP-1, orforglipron (Foundayo™) was FDA approved on April 1, 2026 ATTAIN-1 Trial: ~12.4% average weight loss (~27 lbs) and Improved cholesterol + 1 Daily Support (60 vegetarian capsules) contains a combination of plant extracts Lindsay Maggio, MD, MPH |

It helps many patients eat less, improve blood sugar control, and lose significant weight (Reference)

10.1093/jn/130.5.1437S 248

These observations support continued investigation into how amylin receptor agonists affect metabolic regulation at a mechanistic level

Some online retailers and compounding pharmacies have marketed products claiming to offer "natural" or "bioidentical" versions of semaglutide, but these products are not FDA-approved and may pose significant safety risks

Ozempic is generally a lot more expensive than metformin

Severe Gastrointestinal Distress The most immediate risk of taking a GLP-1 medication too frequently is extreme nausea and vomiting